You are here
- Home
- Total number of clinical trials
A Phase I, Single Centre, Open Study to Assess the Pharmacokinetics of oral AZD6140 after Single Dose in Healthy Japanese Male Volunteers
- Disease
- acute coronary syndrome
- Drug Name
- AZD6140, Brilinta
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- May 19, 2012
- Study Name
- D5133C00001
- ClinicalTrials.gov ID
- NCT01588626
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 25, 2012
- D5133C00001.pdf (269 KB)
